Clinical trials
Anthrax trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emergent BioSolutions | 9 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Elusys Therapeutics | 3 |
| PharmAthene, Inc. | 3 |
| Altimmune, Inc. | 2 |
| Biomedical Advanced Research and Development Authority | 2 |
| BlueWillow Biologics | 1 |
| Bristol-Myers Squibb | 1 |
| Centers for Disease Control and Prevention | 1 |
| DynPort Vaccine Company LLC, A GDIT Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anthrax | 46 |
| Bacillaceae Infections | 1 |
| Bacterial Infections | 1 |
| Basal Cell Carcinoma | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Squamous Cell | 1 |
| Gram-Positive Bacterial Infections | 1 |
| HIV Infections | 1 |
| Head and Neck Neoplasms | 1 |
| Infections | 1 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.